Welcome to our dedicated page for Nature’S Sun news (Ticker: NATR), a resource for investors and traders seeking the latest updates and insights on Nature’S Sun stock.
Nature’s Sunshine Products, Inc. (NASDAQ: NATR) is a natural health and wellness company that manufactures and distributes herbal, nutritional and personal care products in more than 40 countries. As a public company listed on the Nasdaq Capital Market, it regularly releases news that covers product innovation, regional performance, capital markets activity and leadership changes.
Investors and observers following NATR news can expect updates on financial results, including quarterly net sales by segment across Asia, Europe, North America and Latin America & Other, along with commentary on gross margins, adjusted EBITDA and the impact of foreign currency. Earnings releases are typically accompanied by conference call announcements where management discusses business trends, digital initiatives and regional performance.
Nature’s Sunshine also issues news on product launches and relaunches. Recent examples include the relaunch of its Power Line suite of metabolic health supplements—Power Beets, Power Greens, Power Meal and Power Balance—and recognition of Synergy WorldWide’s flagship product Pro-Argi-9+ as the world’s #1 L-arginine supplement in its category, based on Euromonitor International research.
Corporate governance and leadership developments feature prominently in NATR news, such as the appointment of a new Chief Executive Officer and senior supply chain leadership. In addition, the company reports on capital markets transactions, including secondary public offerings by major stockholders and related share repurchase agreements, as well as updates on joint venture arrangements and ownership changes in key international operations.
This news page aggregates these disclosures so readers can track Nature’s Sunshine’s financial performance, product pipeline, strategic initiatives and governance developments over time. For those researching NATR stock or the broader natural health and wellness space, the news flow provides context on how the company manages growth, regulatory complexity, supply chain operations and its global consultant and customer base.
Nature's Sunshine (NASDAQ:NATR) division Synergy Worldwide announced that Euromonitor International named Pro-Argi-9+ the world’s #1 L-arginine supplement by retail sales value for 2024, based on custom research conducted Sept–Oct 2025.
Pro-Argi-9+ is described as an L-arginine complexer combining l-arginine and l-citrulline with polyphenols and antioxidants to support nitric oxide production, circulation, and cardiovascular wellness. Synergy cites the recognition as validation of its science-based nutrition strategy and global field distribution across Asia Pacific and other markets.
Nature’s Sunshine (NASDAQ: NATR) named Erich Fritz as Executive Vice President, Global Supply Chain, effective December 8, 2025. He will report to CEO Ken Romanzi and brings over 40 years of operations, supply chain, and business development experience across consumer goods firms.
Mr. Fritz joins from Wyandot Snacks, where he served as COO and board member, and previously led supply chain at B&G Foods (oversaw 50+ brands across nine manufacturing facilities) and manufacturing at Ocean Spray (led 12 facilities and construction of a major beverage plant). He holds a BS in Management and is an inventor on several patents.
Nature's Sunshine (Nasdaq: NATR) reported Q3 2025 results with net sales up 12% to $128.3M and GAAP EPS $0.30 versus $0.23 a year earlier. Adjusted EBITDA rose 42% to $15.2M and gross margin improved 200 basis points to 73.3%. Net cash from operations for the nine months was $25.4M, cash and equivalents were $95.6M and the company ended the period with zero debt. The company repurchased 1,129,000 shares for $14.4M year-to-date. Management raised full-year 2025 guidance to $476–$480M net sales and $47–$49M adjusted EBITDA and announced CEO Ken Romanzi's appointment.
Nature’s Sunshine (Nasdaq: NATR) will hold its third quarter 2025 conference call on Thursday, November 6, 2025 at 5:00 p.m. ET (3:00 p.m. MT) to discuss financial results for the quarter ended September 30, 2025.
CEO Kenneth Romanzi and CFO Shane Jones will host the call. The company will release results in a press release prior to the call. Participants should dial in 5–10 minutes early for registration.
- Toll-free dial-in: 1-800-717-1738
- International dial-in: 1-646-307-1865
- Conference ID: 34830
- Replay available after 8:00 p.m. ET on Nov 6, 2025 through Nov 20, 2025 (toll-free replay: 1-844-512-2921, replay ID 1134830)
Nature’s Sunshine (Nasdaq: NATR) appointed Kenneth Romanzi as Chief Executive Officer and member of the board, effective October 29, 2025. The board made a unanimous decision following a comprehensive search. Romanzi joins with extensive CPG leadership experience, including prior roles as President and CEO of B&G Foods where full-year revenue grew from $1.6 billion to $2.0 billion, plus executive positions at Nabisco, Naked Juice/The Ultimate Juice Company, Hasbro, and Ocean Spray.
Management expects Romanzi to accelerate digital empowerment of distributors, expand omnichannel offerings, and drive long-term shareholder value while building on existing momentum under outgoing CEO Terrence Moorehead.
Nature’s Sunshine (Nasdaq: NATR) relaunched its Power Line on October 7, 2025, adding a new product, Power Balance, to a four-supplement suite targeting metabolic health.
The updated line includes Power Beets (cardiovascular support), Power Greens (nutrient-dense greens), Power Meal (plant-protein meal replacement with 30+ whole foods), and new Power Balance (premeal metabolic optimizer with a superfood fiber matrix to curb cravings, balance blood sugar, and support the microbiome).
The company positions the suite as a natural, convenient approach to address rising global metabolic health concerns and to complement modern diets.
Nature's Sunshine (NASDAQ:NATR) reported strong Q2 2025 financial results with net sales increasing 4% to $114.8 million compared to $110.6 million in the year-ago quarter. The company's GAAP net income rose significantly to $5.3 million ($0.28 per diluted share) from $1.3 million ($0.07 per diluted share).
Key performance metrics include Adjusted EBITDA growth of 8% to $11.3 million, improved gross profit margin of 71.7%, and strong performance in Japan and Central Europe. The company has revised its full-year 2025 guidance upward, now expecting net sales between $460-$475 million and adjusted EBITDA of $41-$45 million.
Nature's Sunshine Products (NASDAQ: NATR), a leading manufacturer of herbal and nutritional supplements, has scheduled its Q2 2025 earnings conference call for Thursday, July 31, 2025, at 5:00 p.m. ET. CEO Terrence Moorehead and CFO Shane Jones will host the call.
The company will release its financial results before the call, followed by a Q&A session. The call will be accessible via toll-free dial-in (1-800-717-1738) and international dial-in (1-646-307-1865) numbers. A replay will be available until August 14, 2025, and the call will be broadcast live on Nature's Sunshine's website.
Nature's Sunshine Products (NASDAQ: NATR) announced the pricing of a secondary public offering where Fosun Pharma USA will sell up to 2,854,607 shares of common stock at $12.00 per share. The offering is expected to close on June 27, 2025.
While NATR won't receive any proceeds from the offering, the company may purchase up to $15.0 million worth of shares from underwriters as part of its existing share repurchase program. D.A. Davidson & Co. is serving as the sole book-running manager for the offering.
Nature's Sunshine Products (NASDAQ: NATR) has announced a secondary public offering of up to 2,854,607 shares of common stock to be sold by Fosun Pharma USA. The company itself is not selling any shares and will not receive proceeds from the offering. As part of the offering, Nature's Sunshine may purchase up to $15.0 million of shares through its existing share repurchase program, funded by cash on-hand and credit facility.
D.A. Davidson & Co. is serving as the sole book-running manager for the offering, which is being made pursuant to an effective shelf registration statement filed with the SEC on June 9, 2025.
FAQ
What is the current stock price of Nature’S Sun (NATR)?
What is the market cap of Nature’S Sun (NATR)?
